US federal: CBD and cannabis regulation, August 2023

Pressure has mounted on the federal government to regulate CBD products in the years since the 2018 Farm Bill passed. However, there has been a stalemate between Congress and the Food and Drug Administration (FDA), with each side pointing the finger at each other to act and leaving little hope for a break-through in the near future.

Despite most states legalising cannabis for medical and/or recreational use and wide popular support for legalisation, the federal government is only likely to make modest reforms to cannabis policy in the near future.

This report provides detailed analysis around the current regulatory framework in place on a federal level in the US for hemp, CBD, other cannabinoids as well as medical and recreational cannabis.

Free Sample
I'm already a subscriber

Anthony Traurig

Head legal analyst
Anthony focuses on regulatory developments and legal analysis in the US. Anthony has a BA in political science from North Carolina State University and a JD from Charleston School of Law (South Carolina), where he was a senior editor on the law review. He practised law for several years in the United States as a litigator.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization